Abdominal Cocoon

(redirected from Peritoneal Fibrosis)
A descriptive term for the fibrotic encasement of the entire small intestine in sclerosing peritonitis, a spontaneous idiopathic process in young women, which follows peritoneovenous shunting, practolol therapy, peritoneal dialysis, chemotherapy, or in which other unknown toxins stimulate fibroblastic proliferation and reactive fibrosis
Treatment Surgical lysis of adhesions and constricting bands
References in periodicals archive ?
However, its effect on peritoneal fibrosis is unknown.
Peritoneal dialysis (PD) is an effective and beneficial treatment for patients with end-stage renal disease;[sup][1],[2] however, peritoneal fibrosis remains a serious complication of long-term PD patients, and a major cause of PD failure.
sup][20],[21] However, it is currently unknown how CF may affect EMT in peritoneal fibrosis.
TGF-[sz] is the strongest profibrotic factor in EMT of peritoneal mesothelial cells (PMCs) and a key mediator in dialysis-related peritoneal fibrosis.
In rats, PMC EMT is a key event leading to peritoneal fibrosis.
As CF is a common posttranslational modification of many glycoproteins, we will explore other glycoproteins involved in peritoneal fibrosis in the future studies to clarify whether they are also affected by the inhibition of CF.
Our results suggest that regulating CF is a potential therapeutic target in peritoneal fibrosis.
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-[sz]1 signaling.
Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites.
MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis.
Full browser ?